{"data":[{"accessionNo":"0001964306-26-000432","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Bodenhoff Mads","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":3000,"aggregateMarketValue":810562.66,"unitsOutstanding":66189926,"approxSaleDate":"2026-09-08","exchange":"NASDAQ","filedAt":"2026-09-08"},{"accessionNo":"0001973379-26-000330","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"HOLTUG LARS","relationship":"Director","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":236,"aggregateMarketValue":62334.59,"unitsOutstanding":61977408,"approxSaleDate":"2026-09-02","exchange":"NASDAQ","filedAt":"2026-09-02"},{"accessionNo":"0001973379-26-000168","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"JENSEN FLEMMING STEEN","relationship":"Officer, EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":19460,"aggregateMarketValue":4641021.92,"unitsOutstanding":61977408,"approxSaleDate":"2026-05-11","exchange":"NASDAQ","filedAt":"2026-05-11"},{"accessionNo":"0001964306-26-000166","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"SINGEL STINA","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":3782,"aggregateMarketValue":907680,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-09","exchange":"NASDAQ","filedAt":"2026-03-09"},{"accessionNo":"0001964306-26-000153","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"SMITH SCOTT THOMAS","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":10000,"aggregateMarketValue":2400000,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-05","exchange":"NASDAQ","filedAt":"2026-03-06"},{"accessionNo":"0001964306-26-000155","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Bodenhoff Mads","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":10000,"aggregateMarketValue":2375307.91,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-06","exchange":"NASDAQ","filedAt":"2026-03-06"},{"accessionNo":"0001968582-26-000231","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Jan Moller Mikkelsen","relationship":"CEO, Officer","securityClass":"American Depository Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":94000,"aggregateMarketValue":22689720,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-05","exchange":"NASDAQ","filedAt":"2026-03-05"},{"accessionNo":"0001964306-26-000151","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Shu Aimee","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":5583,"aggregateMarketValue":1316554.92,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-05","exchange":"NASDAQ","filedAt":"2026-03-05"},{"accessionNo":"0001964306-26-000150","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"SMITH SCOTT THOMAS","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":10000,"aggregateMarketValue":2400000,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-05","exchange":"NASDAQ","filedAt":"2026-03-05"},{"accessionNo":"0001973379-26-000078","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Shu Aimee","relationship":"Officer, EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":7290,"aggregateMarketValue":1743913.8,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-04","exchange":"NASDAQ","filedAt":"2026-03-04"},{"accessionNo":"0001964306-26-000147","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Morrison Lisa","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":10105,"aggregateMarketValue":2388194.94,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-04","exchange":"NASDAQ","filedAt":"2026-03-04"},{"accessionNo":"0001973379-26-000065","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Fairey William","relationship":"Director","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":1800,"aggregateMarketValue":435762,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000064","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"IMANI SIHAM","relationship":"Director","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":1800,"aggregateMarketValue":435762,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000063","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"SMITH SCOTT THOMAS","relationship":"Officer, EXECUTIVE VP CHIEF FINANCIAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":18349,"aggregateMarketValue":4442109,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000062","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"JENSEN MICHAEL WOLFF","relationship":"Officer, EXECUTUVE VP CHIEF LEGAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":18349,"aggregateMarketValue":4442109,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000061","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Bodenhoff Mads","relationship":"Officer, SENIOR VP PRINCIPAL ACCOUNTING OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":6872,"aggregateMarketValue":1663642,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000060","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG","relationship":"Officer, EXECUTIVE VP CHIEF ADMINISTRATIVE OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":10800,"aggregateMarketValue":2614572,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000059","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Morrison Lisa","relationship":"Director","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":2100,"aggregateMarketValue":508389,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000058","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"HOLTUG LARS","relationship":"Director","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":2100,"aggregateMarketValue":508389,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000057","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"SPROGOE KENNETT","relationship":"Officer, EXECUTIVE VP HEAD OF RESEARCH AND PROD DEVELOPMENT","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":10800,"aggregateMarketValue":2614572,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000056","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"JENSEN FLEMMING STEEN","relationship":"Officer, EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":10800,"aggregateMarketValue":2614572,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000055","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Cha Albert","relationship":"Director","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":2100,"aggregateMarketValue":508389,"unitsOutstanding":61977408,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001973379-26-000011","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"MIKKELSEN JAN MOLLER","relationship":"Officer, PRESIDENT CEO","securityClass":"AMERICAN DEPOSITORY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":86860,"aggregateMarketValue":18413630.85,"unitsOutstanding":61695211,"approxSaleDate":"2026-01-13","exchange":"NASDAQ","filedAt":"2026-01-13"},{"accessionNo":"0001964306-25-000433","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"JENSEN MICHAEL WOLFF","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":10000,"aggregateMarketValue":2081018.69,"unitsOutstanding":61695211,"approxSaleDate":"2025-12-04","exchange":"NASDAQ","filedAt":"2025-12-04"},{"accessionNo":"0001968582-25-001152","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"Jan Moller Mikkelsen","relationship":"CEO, Officer","securityClass":"American Depository Shares","broker":"J.P. Morgan Securities LLC","unitsToSell":100000,"aggregateMarketValue":21085000,"unitsOutstanding":60689487,"approxSaleDate":"2025-12-02","exchange":"NASDAQ","filedAt":"2025-12-02"},{"accessionNo":"0001964306-25-000429","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"SPROGOE KENNETT","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":10000,"aggregateMarketValue":2093222.47,"unitsOutstanding":61695211,"approxSaleDate":"2025-12-02","exchange":"NASDAQ","filedAt":"2025-12-02"},{"accessionNo":"0001964306-25-000428","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"JENSEN FLEMMING STEEN","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":10000,"aggregateMarketValue":2058454.18,"unitsOutstanding":61695211,"approxSaleDate":"2025-12-02","exchange":"NASDAQ","filedAt":"2025-12-02"},{"accessionNo":"0001964306-25-000419","issuerCik":"0001612042","issuerName":"Ascendis Pharma A/S","ticker":"ASND","personName":"SINGEL STINA","relationship":"Officer","securityClass":"American Depositary Shares","broker":"Merrill Lynch","unitsToSell":218,"aggregateMarketValue":45679.72,"unitsOutstanding":61695211,"approxSaleDate":"2025-12-01","exchange":"NASDAQ","filedAt":"2025-12-01"}],"updatedAt":"2026-10-14T08:43:31.552Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}